Wladimir Hogenhuis
Director/Board Member at REZOLUTE, INC.
Net worth: 53 943 $ as of 2024-02-28
Profile
Presently, Wladimir Hogenhuis holds the position of President, Chief Executive Officer & Director at Driver Bioengineering, Inc. Mr. Hogenhuis is also on the board of Rezolute, Inc., GATT Technologies BV and IHP Therapeutics, Inc.
Mr. Hogenhuis previously was Chief Operating Officer of Ultragenyx Pharmaceutical, Inc., General Manager-Neuroscience at Merck & Co., Inc. and Senior Vice President for GSK Plc.
Wladimir Hogenhuis received a doctorate from the University of Leiden and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REZOLUTE, INC.
0.08% | 2024-01-22 | 32,693 ( 0.08% ) | 53 943 $ | 2024-02-28 |
Wladimir Hogenhuis active positions
Companies | Position | Start |
---|---|---|
REZOLUTE, INC. | Director/Board Member | 2021-03-01 |
GATT Technologies BV
GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Director/Board Member | 2020-04-30 |
IHP Therapeutics, Inc. | Director/Board Member | - |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Chief Executive Officer | 2022-04-27 |
Former positions of Wladimir Hogenhuis
Companies | Position | End |
---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Chief Operating Officer | 2020-01-09 |
GSK PLC | Corporate Officer/Principal | 2018-08-31 |
Vision 2020 | Director/Board Member | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Wladimir Hogenhuis
University of Leiden | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
GSK PLC | Health Technology |
Private companies | 5 |
---|---|
Vision 2020 | |
Rezolute, Inc. | |
GATT Technologies BV
GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
IHP Therapeutics, Inc. |